FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer

被引：0
|
作者：
F Bertolini
N Malavasi
L Scarabelli
F Fiocchi
B Bagni
C Del Giovane
G Colucci
G E Gerunda
R Depenni
S Zironi
A Fontana
E Pettorelli
G Luppi
P F Conte
机构：
[1] Oncology,Haematology and Respiratory Diseases Department
[2] University Hospital of Modena,Nuclear Medicine Division
[3] Radiology Institute,Multiorgan Transplantation Division
[4] University Hospital of Modena,undefined
[5] University Hospital of Modena,undefined
[6] General Surgery,undefined
[7] Vignola Hospital,undefined
[8] Azienda USL Modena,undefined
[9] University Hospital of Modena,undefined
来源：
British Journal of Cancer | 2011年 / 104卷
关键词：
bevacizumab; liver metastases; colorectal cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1079 / 1084
页数：5
相关论文
共 50 条
  • [21] Effectiveness of neoadjuvant chemotherapy including bevacizumab in patients with resectable colorectal cancer liver metastases
    Gruenberger, B.
    Scheithauer, W.
    Tamandl, D.
    Zielinski, C.
    Schueller, J.
    Gruenberger, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [22] Phase II trial to evaluate combination of folfox6+bevacizumab in initially unresectable liver metastases from colorectal cancer (crc)
    Malavasi, N.
    Dealis, C.
    Depenni, R.
    Zironi, S.
    Bertolini, F.
    Losi, L.
    Gerunda, G. E.
    Colucci, G.
    Luppi, G.
    Conte, P. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [23] Chemotherapy in Patients with Resectable Liver Metastases from Colorectal Cancer
    Hebbar, Mohamed
    CURRENT COLORECTAL CANCER REPORTS, 2005, 1 (01) : 34 - 40
  • [24] Phase II trial of FOLFOX6 plus Bevacizumab for patients with unresectable liver and only hepatic metastasis from colorectal cancer: A first preliminary analysis of the safety
    Depenni, R.
    Dealis, C.
    Perrone, S.
    Losi, L.
    Bertolini, F.
    Malavasi, N.
    Zironi, S.
    Luppi, G.
    Conte, P. F.
    ANNALS OF ONCOLOGY, 2006, 17 : XI46 - XI46
  • [25] The management of resectable and unresectable liver metastases from colorectal cancer
    Kemeny, Nancy
    CURRENT OPINION IN ONCOLOGY, 2010, 22 (04) : 364 - 373
  • [26] Neoadjuvant FOLFIRI plus bevacizumab in patients with resectable liver metastases from colorectal cancer: a phase 2 trial
    Nasti, G.
    Piccirillo, M. C.
    Izzo, F.
    Ottaiano, A.
    Albino, V.
    Delrio, P.
    Romano, C.
    Giordano, P.
    Lastoria, S.
    Caraco, C.
    di Castelguidone, E. de Lutio
    Palaia, R.
    Daniele, G.
    Aloj, L.
    Romano, G.
    Iaffaioli, R. V.
    BRITISH JOURNAL OF CANCER, 2013, 108 (08) : 1566 - 1570
  • [27] Neoadjuvant FOLFIRI+bevacizumab in patients with resectable liver metastases from colorectal cancer: a phase 2 trial
    G Nasti
    M C Piccirillo
    F Izzo
    A Ottaiano
    V Albino
    P Delrio
    C Romano
    P Giordano
    S Lastoria
    C Caracò
    E de Lutio di Castelguidone
    R Palaia
    G Daniele
    L Aloj
    G Romano
    R V Iaffaioli
    British Journal of Cancer, 2013, 108 : 1566 - 1570
  • [28] MULTICENTER PHASE II STUDY OF FOLFOX6 AS NEOADJUVANT CHEMOTHERAPY FOR PATIENTS WITH UNRESECTABLE LIVER-ONLY METASTASES FROM COLORECTAL CANCER IN JAPAN; ROOF STUDY
    Shibata, Y.
    Takahashi, T.
    Tojima, Y.
    Tsuboi, K.
    Sakamoto, E.
    Kunieda, K.
    Matsuoka, H.
    Suzumura, K.
    Sakamoto, J.
    Kondo, K.
    ANNALS OF ONCOLOGY, 2010, 21 : 220 - 220
  • [29] Modified Folfox6 as Adjuvant Chemotherapy in Vietnamese Patients With Colorectal Cancer
    Nguyen T Quang
    Bui T Oanh
    Tran P Thao
    Tran V Thuan
    Nguyen V Hieu
    Chu Q Hoan
    Bui T A Tuyet
    Le N Quynh
    Le V Quang
    Dao V Tu
    CANCER CONTROL, 2019, 26 (01)
  • [30] Liver transplantation for non-resectable colorectal liver metastases
    Aziz, Hassan
    Sharif, Saima
    Gribovskaja-Rupp, Irena
    Hemming, Alan W.
    HEPATOBILIARY SURGERY AND NUTRITION, 2023, 12 (04) : 595 - 597
12345